Exact Mass: 566.2176668

Exact Mass Matches: 566.2176668

Found 447 metabolites which its exact mass value is equals to given mass value 566.2176668, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

100-1

(3R)-3,8-dihydroxy-9-[(2R,4R,5R,6R)-5-hydroxy-4-[(2S,5S,6S)-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6-methyl-tetrahydropyran-2-yl]-3-methyl-2,4-dihydrobenzo[a]anthracene-1,7,12-trione

C31H34O10 (566.2151864)

N-[6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide

N-[6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-{2-hydroxy-1H-imidazo[4,5-b]pyridin-1-yl}piperidine-1-carboximidate

C26H27F5N6O3 (566.2064692)

PA(2:0/6 keto-PGF1alpha)

[(2R)-3-(acetyloxy)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)propoxy]phosphonic acid

C25H43O12P (566.2492007999999)

PA(2:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/6 keto-PGF1alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(6 keto-PGF1alpha/2:0)

[(2R)-2-(acetyloxy)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)propoxy]phosphonic acid

C25H43O12P (566.2492007999999)

PA(6 keto-PGF1alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/2:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/TXB2)

[(2R)-3-(acetyloxy)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H43O12P (566.2492007999999)

PA(2:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/TXB2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(TXB2/2:0)

[(2R)-2-(acetyloxy)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H43O12P (566.2492007999999)

PA(TXB2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/2:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Thielavin B

C31H34O10 (566.2151864)

Alopecurone C

C34H30O8 (566.194058)

Decinnamoyltaxagifine

5alpha-Decinnamoyltaxigifine

C28H38O12 (566.2363148)

N,N-Bisnoraromoline

(+)-N,N-Bisnoraromoline

C34H34N2O6 (566.2416744)

16-Hydroxymilolide M

(+)-16-Hydroxymilolide M

C28H38O12 (566.2363148)

Fraxiresinol 4-O-beta-D-glucopyranoside

C27H34O13 (566.1999314)

Okaramine B

C33H34N4O5 (566.2529074)

Briarlide K

C28H38O12 (566.2363148)

Thielavin O

C31H34O10 (566.2151864)

Pachyclavulide G

C28H38O12 (566.2363148)

4-Methoxy-3,3,5-trihydroxystilbene 3-O-beta-D-(2-O-p-coumaryl)-glucopyranoside

C30H30O11 (566.178803)

(+)-Bisnorobamegine

N,N-Didemethylobamegine

C34H34N2O6 (566.2416744)

(-)-Digracine

C34H34N2O6 (566.2416744)

Genameside C

C23H34O16 (566.1846764000001)

Genameside D

C23H34O16 (566.1846764000001)

Monodictyochrome B

C30H30O11 (566.178803)

Swietmanin I

C32H38O9 (566.2515698)

Methylisohaenkeanoside

C27H34O13 (566.1999314)

methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate

methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate

C23H34O16 (566.1846764000001)

(+)-11alpha,20alpha-epoxyjunceellolide D

C28H38O12 (566.2363148)

Brunneogaleatoside

C27H34O13 (566.1999314)

(5S,6R,7R,8S)-2-(2-Phenylethyl)-5,6,7-tri-hydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH13)|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|AH13

(5S,6R,7R,8S)-2-(2-Phenylethyl)-5,6,7-tri-hydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH13)|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|AH13

C34H30O8 (566.194058)

C27H34O13

C27H34O13 (566.1999314)

(1aR,1bS,2S,5aS,6S,6aS)-2-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-5-carboxylic acid methyl ester|6-O-beta-D-glucopyranosylphlorigidoside C

(1aR,1bS,2S,5aS,6S,6aS)-2-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-5-carboxylic acid methyl ester|6-O-beta-D-glucopyranosylphlorigidoside C

C23H34O16 (566.1846764000001)

(+)-Syringaresinol-O-beta-D-glucoside

C27H34O13 (566.1999314)

methyl ester of methylgrandifloroside

C27H34O13 (566.1999314)

10-O-beta-D-glucopyranosyltheviridoside

C23H34O16 (566.1846764000001)

MS000047657

C35H34O7 (566.2304414)

butyl isoligustrosidate

C28H38O12 (566.2363148)

(+)-Pangkoramine

C34H34N2O6 (566.2416744)

6-O-beta-D-glucopyranosyltheviridoside

C23H34O16 (566.1846764000001)

4-Me ether,3-O-rutinoside-Piceatannol

C27H34O13 (566.1999314)

rhaponticin 2-O-p-coumarate

C30H30O11 (566.178803)

(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|(5S,6S,7S,8R)-2-(2-Phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH14)|AH10

(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|(5S,6S,7S,8R)-2-(2-Phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH14)|AH10

C34H30O8 (566.194058)

daturametelin E

C29H42O9S (566.2549402000001)

(1R,2S,4S,5S,6R,7S,8S,9R,10S)-1-acetoxy-9-benzoyloxy-8-trans-cinnamoyloxy-2,4,6-trihydroxydihydro-beta-agarofuran

C32H38O9 (566.2515698)

(rel)-(1R,4aS,8S,8aS)-8-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-4,4a,8,8a-tetrahydro-1-methyl-3-oxo-1H,3H-pyrano[3,4-c]pyran-5-carboxylic acid methyl ester|lamiuamplexoside B

C23H34O16 (566.1846764000001)

(2R,3S,4S)-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-4-[(4-hydroxy-3-methoxyphenyl)methyl]tetrahydrofuran 3-{[(2R)-2-carbomethoxy-2-hydroxy]ethyl}benzoate|hyosmin

C31H34O10 (566.2151864)

C28H39ClN2O8

C28H39ClN2O8 (566.2394804)

(+/-)-Lyoniresinol 2alpha-O-rhamnoside

C28H38O12 (566.2363148)

guangsangon B

C34H30O8 (566.194058)

Tetra-Ac-Ptaquiloside

C28H38O12 (566.2363148)

(+)-9-O-trans-feruloyl-5-methoxyariciresinol

C31H34O10 (566.2151864)

glansreginin B

C24H38O15 (566.2210598)

Rhaponticin 6-O-(E)-p-coumarate

C30H30O11 (566.178803)

(l(-)-tyrosyl)=>glutaminyl=>glutaminyl=>-glutamic acid|(l(-)-Tyrosyl)=>glutaminyl=>glutaminyl=>-glutaminsaeure

C24H34N6O10 (566.2336304)

Renieramycin E

C30H34N2O9 (566.2264194)

piceid 2-O-(E)-ferulate

C30H30O11 (566.178803)

monodictyochromone A

C30H30O11 (566.178803)

A chromanone isolated from the marine derived fungus Monodictys putredinis and exhibits inhibitory activity against P450.

10-(6-O-trans-sinapoyl-beta-D-glucopyranosyl)gardendiol|11-(6-O-trans-sinapoyl-beta-glucopyranosyl)gardendiol

C27H34O13 (566.1999314)

arbortristoside A

C27H34O13 (566.1999314)

Lappaol D

C32H38O9 (566.2515698)

lactuberin B

C27H34O13 (566.1999314)

neoadenoloside A

C28H38O12 (566.2363148)

lyoniresinol-3alpha-O-beta-arabinopyranoside

C28H38O12 (566.2363148)

Citrusin B

C27H34O13 (566.1999314)

12-O-butenoyl-5-hydroxy-6,7-epoxy-resiniferonol-9,13,14-orthobenzoate

C31H34O10 (566.2151864)

4-methoxy-9,10-dihydrophenanthrene-2,7-di-O-beta-D-glucopyranoside

C27H34O13 (566.1999314)

pharbilignoside

C28H38O12 (566.2363148)

(2E)-1-{2,4-dihydroxy-6-methoxy-3-[(2R,4S,6S)-tetrahydro-2-(4-hydroxyphenyl)-6-(2-phenylethyl)-2H-pyran-4-yl]phenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one|Katsumain D

C35H34O7 (566.2304414)

chalcocaryanone C

C34H30O8 (566.194058)

(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-4-[(2S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-2-(4-hydroxyphenyl)-7-methoxy-2H-1-benzopyran-6-yl}-3-phenylprop-2-en-1-one|katsumain E

C35H34O7 (566.2304414)

(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4-[(2S)-2-hydroxy-4-phenylbutyl]-7-methoxy-2H-1-benzopyran-6-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one|katsumain G

C35H34O7 (566.2304414)

(+)-lyoniresinol-3alpha-O-alpha-L-rhamonopyranoside

C28H38O12 (566.2363148)

1-O-methylisocurculigine tetra-O-methyl ether

C28H38O12 (566.2363148)

teulamioside

C28H38O12 (566.2363148)

E-3-[3-(benzoyloxymethyl)-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydrobenzo[b]furan-5-yl]prop-2-enyl benzoate

C34H30O8 (566.194058)

Fraxiresinol 1-O-glucoside

C27H34O13 (566.1999314)

cis-7-feruloylloganin

C27H34O13 (566.1999314)

(-)-crinemodin bianthrone|Crinemodin bianthrone

C34H30O8 (566.194058)

10-O-beta-D-fructofuranosyltheviridoside

C23H34O16 (566.1846764000001)

10-methyl-11-glucosyl forsythide

C23H34O16 (566.1846764000001)

humanteniridine

C31H38N2O8 (566.2628028)

3-O-beta-D-glucopyranosyltheviridoside

C23H34O16 (566.1846764000001)

(aS)-(5R,6S,7R,8R)-8-benozyloxy-5,6,7,8-tetrahydro-1,5-dihydroxy-3,12-dihydroxy-1,2,10,11-tetramethoxy-6,7-dimethyldibenzo[a,c]cycloocten-5-yl acetate|kadsuphilin I

C31H34O10 (566.2151864)

BRN 2931802

C32H38O9 (566.2515698)

Hedyotol B

C31H34O10 (566.2151864)

violide E

C28H38O12 (566.2363148)

(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22-23,26,24,25-triepoxy-12-ethoxy-6beta,17beta,26-trihydroxyergosta-2-en-1-one|12-O-ethyl-jaborosalactol 25|12-O-ethyljaborosalactol 25

C30H43ClO8 (566.2646308000001)

10-(6-O-trans-sinapoyl-beta-glucopyranosyl)gardendiol|11-(6-O-trans-sinapoyl-beta-D-glucopyranosyl)gardendiol

C27H34O13 (566.1999314)

(8R,7S,8R*)-5,5-dimethoxy-7-oxolariciresinol 9-O-beta-D-xylopyranoside

(8R*,7S*,8R*)-5,5-dimethoxy-7-oxolariciresinol 9-O-beta-D-xylopyranoside

C27H34O13 (566.1999314)

5-methylresveratrol-3,4-O-beta-D-diglucopyranoside

C27H34O13 (566.1999314)

erybraedin D hemiethyl phthalate

C35H34O7 (566.2304414)

trigochinin G

C32H38O9 (566.2515698)

Javanicolide D

C28H38O12 (566.2363148)

C34H30O8

C34H30O8 (566.194058)

monodictyochromone B

C30H30O11 (566.178803)

A chromanone isolated from the marine derived fungus Monodictys putredinis and exhibits inhibitory activity against P450.

NSC357286

C34H30O8 (566.194058)

Asn Tyr Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]butanedioic acid

C23H34N8O9 (566.2448634)

Asn Tyr Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C23H34N8O9 (566.2448634)

Okaramine B_120148

C33H34N4O5 (566.2529074)

4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoic acid

NCGC00347452-02!4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoic acid

C31H34O10 (566.2151864)

C23H34O16_beta-D-Glucopyranose, 1-[2-[(2S,3E,4S)-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetate]

NCGC00169081-02_C23H34O16_beta-D-Glucopyranose, 1-[2-[(2S,3E,4S)-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetate]

C23H34O16 (566.1846764000001)

thielavin B_major

C31H34O10 (566.2151864)

methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_major

C23H34O16 (566.1846764000001)

methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_98.3\\%

C23H34O16 (566.1846764000001)

Ala Gln Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid